Variant Perception

Where We Disagree With the Market

The market is treating the Q1 FY2026 residential data ARPU print of $79.51 as the long-feared back-book break — but management explicitly attributed the sequential drop to acquisition-mix and front-book promotional discounts, and the $2-$5 back-book reset they have telegraphed for FY2026 has not yet been executed. That conflation matters because both bull and bear consensus have agreed the back book is the load-bearing variable, and consensus is now mispricing the trigger as already pulled. A second, related disagreement: the October 2026 MBI close is consensus-modelled as a covenant stress event, but the arithmetic ends a recurring $138M equity-method drain and is mildly deleveraging on a per-turn basis — Moody's models the same. Where consensus has it right: the underlying franchise is shrinking, leverage is real, and execution under a new CEO is unproven. Where the report's evidence disagrees with consensus is narrower and more observable than the headline tape implies.

Variant Perception Scorecard

Consensus clarity is high because the tape, the analyst-target sweep, the credit-rating action, the 13% short interest, and the "Reduce" consensus all point the same direction — there is little ambiguity about what the market believes. The variant strength is medium, not high, because the disagreement is about the timing and composition of an admitted deterioration, not about whether deterioration is occurring. Evidence strength is solid for the ARPU-mix and MBI-arithmetic legs (sourced to transcript attribution, the Moody's leverage path, and the forensic add-back ledger) and softer for the management-credibility leg, which is read-on-a-package rather than measurable. Resolution arrives in two distinct windows: Q2 FY2026 earnings (~July 30) tests the ARPU attribution; the October 1 MBI close and the Q3 FY2026 consolidated print test the leverage arithmetic. Both fall within the next five months.

Consensus Map

The Disagreement Ledger

On disagreement #1 (ARPU attribution). A consensus analyst would say the Q1 FY2026 ARPU print is the single cleanest signal in two years and proves that competitive intensity has reached the install base; the multi-quarter softening from $80.71 (Q4 FY25) to $79.51 (Q1 FY26) is exactly the pattern the bears flagged. The report's evidence disagrees because management's transcript attribution puts the move in acquisition pricing — promotional rates offered to new customers in competitive markets — and the disclosed $2-$5 back-book reset is described as a forward action, not one already executed. If we are right, the market would have to concede that the disconfirming signal is not yet triggered and that the bull tab's $5,000 net-add narrowing path with stable ARPU is still alive; the cleanest disconfirming signal is a Q2 FY2026 sequential ARPU below $78.70 or any explicit confirmation that the back-book reset has begun. A second confirmatory signal in either direction would be CABO publishing a front-book/back-book ARPU split — the absence of which is itself informative about why management has not.

On disagreement #2 (MBI arithmetic). A consensus analyst would call MBI the most poorly timed acquisition possible into a declining-revenue core business and a covenant stress event waiting to land. The report's evidence — equity-method losses of $204M (FY24) and $138M (FY25) on the minority MBI stake, plus $146M of MBI Net Option fair-value losses in FY24 and $52M in FY25 — says MBI was already costing the bonus metric well over $200M annually; consolidation ends that drain while adding ~$100M of consolidated EBITDA against ~$870M of incremental debt. Moody's December 2025 downgrade modeled the same path: leverage at 4.1-4.3x at close, improving toward 3.8-4.1x by YE27, with a stable outlook. If we are right, the market would have to concede that MBI close is not the trigger event everyone is waiting for and that the post-close consolidated cash engine is incrementally cleaner, not dirtier. The disconfirming signal is the Q3 FY2026 consolidated leverage print landing above 4.5x with integration cost language widening the non-GAAP add-back stack.

On disagreement #3 (leverage cascade requires two independent legs). A consensus analyst would point at ATUS as the obvious cautionary parallel and at the $1.71B variable-rate term loan as the smoking gun. The report's evidence — that ~85% of the debt stack is fixed or synthetically fixed below market through 2027-2028, and that the March 2026 convertible take-out has already cleared the largest near-dated maturity — says the cascade math requires both an operating collapse and a refinancing repricing, and the second leg is structurally protected for the next 18-24 months. If we are right, the bear's own named cover signal (unsecured refi at par below 7.5% coupon) is more likely to arrive than the bear's framework assumes, and the leverage leg can be resolved independently of the operating leg. The disconfirming signal is a refinancing pushed late at materially wider spreads, or any equity-raise-as-deleveraging discussion appearing in disclosure.

On disagreement #4 (Holanda package). A consensus analyst reads the Holanda hire as an unambiguous credibility positive — outside industry veteran, CEO/Chair split, alignment incentives. The report's evidence — $10M inducement equity, all PSU and bonus metrics anchored on the same Adj EBITDA stack that excludes $138M of equity-method losses and the impairment line, zero starting share ownership against a five-year guideline — says the structure is paid-to-manage-the-decline, not paid-to-stabilize-the-base. If we are right, the multi-year capital allocation framework that consensus is implicitly expecting (probable Q3-Q4 FY2026) will not deliver the credibility re-rate the bull case is hoping for. The cleanest disconfirming signal is Holanda himself making an open-market share purchase before the five-year mechanical guideline forces him to.

Evidence That Changes the Odds

How This Gets Resolved

What Would Make Us Wrong

The strongest case against the ARPU-attribution variant is the simplest one: management's own attribution of the Q1 FY2026 move to "acquisition efforts at lower promotional rates" is the explanation a management team gives when it does not want to confirm a back-book reset, and the same team carried "sustained growth" language through four quarters of accelerating sub losses before the Q1 FY2025 break. The story tab flags this pattern explicitly; we should not assume the next attribution is the honest one. If Q2 FY2026 ARPU prints below $78.70, the variant view collapses, and not in a way that can be rescued by parsing the transcript more carefully. The reflexive impairment that fed the $586M franchise/goodwill write-down is the same mechanism that re-triggers if the stock weakens further from here — both legs of the disagreement (ARPU attribution and MBI arithmetic) need to be roughly right for the equity to re-rate, and they are not independent of each other.

The strongest case against the MBI arithmetic variant is integration cost surprise. Moody's leverage path assumes integration cost is bounded and wraps within two quarters; the forensic tab notes that the system-conversion cost line has already grown from $7M (FY24) to $18.6M (FY25) inside the existing Adj EBITDA bridge, and MBI is a 210K-subscriber acquisition into a new operating footprint with the new CEO's team simultaneously absorbing it. If integration cost runs at 1.5-2x the projected rate, the post-close Adj EBITDA stack widens, the metric does not get cleaner, and the bonus/covenant denominator becomes harder to defend. A second leg: Moody's stable outlook depends on management's stated leverage target (high-2x to low-3x) which the FY25 cash trajectory does not yet support without MBI's EBITDA contribution landing exactly as modeled.

The leverage-cascade-protection variant assumes the variable-rate hedges hold through 2027-2028 and that a par refinancing arrives. If rates re-accelerate or if CABO's spread widens before the refinancing window opens, the bear's threshold for the cover signal (7.5% coupon) is exactly where the issuance would price — meaning the disagreement on this leg has a knife-edge resolution, not a wide-margin one. And the Holanda variant on the package structure is read-on-a-package rather than measurable; we will only find out when the multi-year framework is published, and either reading remains consistent with the evidence on the table today.

The right way to hold all four disagreements at once: they are sequenced, not independent. The ARPU print decides #1, the MBI close decides #2, the refinancing announcement decides #3, and the multi-year framework decides #4. The first three resolve inside six months. None of them require a contrarian view of the franchise or the moat or the leverage; all four require a more precise read of what consensus is already arguing about.

The first thing to watch is the Q2 FY2026 sequential residential data ARPU print, expected ~July 30, 2026 — a hold at or above $79.51 with stable mix means the back-book reset is still forward, not triggered, and everything else on this page comes alive.